OSDH releases updates on treatments for COVID-19

The Oklahoma State Department of Health (OSDH) is committed to sharing the most up to date and timely information about the COVID-19 pandemic. Monday, the FDA removed the authorization for the use of two monoclonal antibody treatments that have been on the market, REGEN-COV and Bam/Ete, due to their ineffectiveness against the omicron variant, taking into consideration the prevalence of omicron…